Federal Register / Vol. 87, No. 86 / Wednesday, May 4, 2022 / Notices 26359 

overarching plan that defines the scope 

of the individual collections that would 

fall under its umbrella. On October 23, 

2011, OMB approved our initial request 

to use the generic clearance process 

under control number 0938–1148 

(CMS–10398). It was last approved on 

April 26, 2021, via the standard PRA 

process which included the publication 

of 60- and 30-day Federal Register 

notices. The scope of the April 2021 

umbrella accounts for Medicaid and 

CHIP State plan amendments, waivers, 

demonstrations, and reporting. This 

Federal Register notice seeks public 

comment on one or more of our 

collection of information requests that 

we believe are generic and fall within 

the scope of the umbrella. Interested 

persons are invited to submit comments 

regarding our burden estimates or any 

other aspect of this collection of 

information, including: the necessity 

and utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments must be received by 

May 18, 2022. 

ADDRESSES: When commenting, please 

reference the applicable form number 

(see below) and the OMB control 

number (0938–1148). To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: CMS–10398 (#59)/OMB 

control number: 0938–1148, Room C4– 

26–05, 7500 Security Boulevard, 

Baltimore, Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may access CMS’ 

website at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Following 

is a summary of the use and burden 

associated with the subject information 

collection(s). More detailed information 

can be found in the collection’s 

supporting statement and associated 

materials (see ADDRESSES). 

Generic Information Collections 

1. Title of Information Collection: 

Medicaid Section 1115 Severe Mental 

Illness and Children with Serious 

Emotional Disturbance Demonstrations; 

Type of Information Collection Request: 

Revised; Use: As part of the metaanalysis, this April 2022 iteration 

proposes to add virtual interviews with 

leaders in the state Medicaid Agency 

and/or the single state agency for 

behavioral health in the states that have 

approved section 1115 SMI 

demonstrations. Otherwise, there are no 

changes to the active collection of 

information requirements that are 

associated with the Implementation 

Plan, the Monitoring Protocol, the 

Monitoring Report, and the Initial 

Availability Assessment. Form Number: 

CMS–10398 (#59) (OMB control 

number: 0938–1148); Frequency: Yearly, 

quarterly, once, and occasionally; 

Affected Public: State, Local, or Tribal 

Governments; Number of Respondents: 

10; Total Annual Responses: 114; Total 

Annual Hours: 3,314. (For policy 

questions regarding this collection 

contact Danielle Daly at 443–379–3289.) 

Dated: April 29, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–09572 Filed 5–3–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifiers CMS–460] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

July 5, 2022. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: llll, Room C4– 

26–05, 7500 Security Boulevard, 

Baltimore, Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 


khammond on DSKJM1Z7X2PROD with NOTICES
26360 Federal Register / Vol. 87, No. 86 / Wednesday, May 4, 2022 / Notices 

and associated materials (see 

ADDRESSES). 

CMS–460 Medicare Participating 

Physician or Supplier Agreement 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Title of Information Collection: 

Medicare Participating Physician or 

Supplier Agreement; Type of 

Information Collection Request: 

Revision with change of a currently 

approved collection; Use: Form CMS– 

460 is the agreement a physician, 

supplier, or their authorized official 

signs to become a participating provider 

in Medicare Part B. By signing the 

agreement to participate in Medicare, 

the physician, supplier, or their 

authorized official agrees to accept the 

Medicare-determined payment for 

Medicare covered services as payment 

in full and to charge the Medicare Part 

B beneficiary no more than the 

applicable deductible or coinsurance for 

the covered services. For purposes of 

this explanation, the term ‘‘supplier’’ 

means certain other persons or entities, 

other than physicians, that may bill 

Medicare for Part B services (e.g., 

suppliers of diagnostic tests, suppliers 

of radiology services, durable medical 

suppliers (DME) suppliers, nurse 

practitioners, clinical social workers, 

physician assistants). Institutions that 

render Part B services in their outpatient 

department are not considered 

‘‘suppliers’’ for purposes of this 

agreement. Form Number: CMS–460 

(OMB control number: 0938–0373); 

Frequency: Annually; Affected Public: 

Private Sector, Business or other forprofits; Number of Respondents: 36,000; 

Number of Responses: 36,000; Total 

Annual Hours: 9,000. (For questions 

regarding this collection contact Mark 

G. Baldwin at 410–786–8139.) 

Dated: April 29, 2022, 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–09574 Filed 5–3–22; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Meeting of the National Vaccine 

Advisory Committee 

AGENCY: Office of Infectious Disease and 

HIV/AIDS Policy, Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the National Vaccine Advisory 

Committee (NVAC) will hold an inperson meeting. The meeting will be 

open to the public and public comment 

will be heard during the meeting. 

DATES: The meeting will be held June 

15–16, 2022. The confirmed meeting 

times and agenda will be posted on the 

NVAC website at http://www.hhs.gov/ 

nvpo/nvac/meetings/index.html as soon 

as they become available. 

ADDRESSES: Instructions regarding 

attending this meeting will be posted 

online at: http://www.hhs.gov/nvpo/ 

nvac/meetings/index.html at least one 

week prior to the meeting. Preregistration is required for those who 

wish to attend the meeting or participate 

in public comment. Please register at 

http://www.hhs.gov/nvpo/nvac/ 

meetings/index.html. 

FOR FURTHER INFORMATION CONTACT: Ann 

Aikin, Acting Designated Federal 

Officer, at the Office of Infectious 

Disease and HIV/AIDS Policy, U.S. 

Department of Health and Human 

Services, Mary E. Switzer Building, 

Room L618, 330 C Street SW, 

Washington, DC 20024. Email: nvac@

hhs.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to Section 2101 of the Public Health 

Service Act (42 U.S.C. 300aa–1), the 

Secretary of HHS was mandated to 

establish the National Vaccine Program 

to achieve optimal prevention of human 

infectious diseases through 

immunization and to achieve optimal 

prevention against adverse reactions to 

vaccines. The NVAC was established to 

provide advice and make 

recommendations to the Director of the 

National Vaccine Program on matters 

related to the Program’s responsibilities. 

The Assistant Secretary for Health 

serves as Director of the National 

Vaccine Program. 

The NVAC will hear presentations on 

innovation for immunization, vaccine 

safety, and communication, and 

surveillance. Please note that agenda 

items are subject to change, as priorities 

dictate. Information on the final meeting 

agenda will be posted prior to the 

meeting on the NVAC website: http://

www.hhs.gov/nvpo/nvac/index.html. 

Members of the public will have the 

opportunity to provide comment at the 

NVAC meeting during the public 

comment period designated on the 

agenda. Public comments made during 

the meeting will be limited to three 

minutes per person to ensure time is 

allotted for all those wishing to speak. 

Individuals are also welcome to submit 

written comments in advance. Written 

comments should not exceed three 

pages in length. Individuals submitting 

comments should email their written 

comments or their request to provide a 

comment during the meeting to nvac@

hhs.gov at least five business days prior 

to the meeting. 

Dated: April 5, 2022. 

Ann Aikin, 

Acting Designated Federal Official, Office of 

the Assistant Secretary for Health. 

[FR Doc. 2022–09551 Filed 5–3–22; 8:45 am] 

BILLING CODE 4150–44–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Membership on the National Vaccine 

Advisory Committee 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office of Infectious Disease and 

HIV/AIDS Policy. 

ACTION: Notice. 

SUMMARY: The Office of Infectious 

Disease and HIV/AIDS Policy (OIDP), a 

program office within the Office of the 

Assistant Secretary for Health, 

Department of Health and Human 

Services (HHS), solicits nominations of 

qualified candidates to be considered 

for appointment to the National Vaccine 

Advisory Committee (NVAC). The 

activities of this committee are governed 

by the Federal Advisory Committee Act 

(FACA). 

The NVAC serves an advisory role, 

providing recommendations to the 

Assistant Secretary for Health in her 

capacity as the Director of the National 


khammond on DSKJM1Z7X2PROD with NOTICES